Northera (Droxidopa) Research Study in POTS and Vasovagal Syncope
Dr. Julian Stewart's team at New York Medical College is seeking people ages 18-35 years of age who have Postural Orthostatic Tachycardia Syndrome (POTS) or have had frequent postural fainting episodes (Vasovagal Syncope) to participate in a New York Medical College research protocol.
We are recruiting patients who faint with at least 2 episodes of vasovagal fainting in the past 12 months and patients with POTS who have had symptoms for 6 months or more. You do not have not have [sic] POTS and VVS to participate.
It is thought that many of the symptoms of orthostatic intolerance are caused by abnormalities in the way in which blood volume (the amount of blood in your circulatory system) shifts when you go from lying down to standing upright. Blood pressure is maintained by the contraction of blood vessels. We want to determine whether Northera (droxidopa) will improve blood vessel contraction in VVS and POTS and whether this improves patients' quality-of-life.
